Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Net Cash Flow (2019 - 2025)

Historic Net Cash Flow for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to -$36.7 million.

  • Strata Critical Medical's Net Cash Flow fell 42244.37% to -$36.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 11216.89%. This contributed to the annual value of -$9.3 million for FY2024, which is 3939.75% up from last year.
  • Per Strata Critical Medical's latest filing, its Net Cash Flow stood at -$36.7 million for Q3 2025, which was down 42244.37% from $24.5 million recorded in Q2 2025.
  • Strata Critical Medical's 5-year Net Cash Flow high stood at $185.0 million for Q2 2022, and its period low was -$336.2 million during Q3 2021.
  • For the 5-year period, Strata Critical Medical's Net Cash Flow averaged around -$9.2 million, with its median value being -$2.0 million (2021).
  • The largest annual percentage gain for Strata Critical Medical's Net Cash Flow in the last 5 years was 714404.26% (2021), contrasted with its biggest fall of 8270401.91% (2021).
  • Quarter analysis of 5 years shows Strata Critical Medical's Net Cash Flow stood at -$4.3 million in 2021, then plummeted by 98.76% to -$8.6 million in 2022, then dropped by 7.24% to -$9.3 million in 2023, then surged by 82.2% to -$1.6 million in 2024, then tumbled by 2123.39% to -$36.7 million in 2025.
  • Its last three reported values are -$36.7 million in Q3 2025, $24.5 million for Q2 2025, and $15.9 million during Q1 2025.